LISA CLARK: Open Payments
NPI 1114317054 · NEW ALBANY, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 32 payments from 16 companies in 2025. Trend: 2023 $580 · 2024 $685 · 2025 $762
Food & beverage: $762
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $235 |
| Dendreon Pharmaceuticals LLC | 7 | $145 |
| Sumitomo Pharma America, Inc. | 4 | $83 |
| PFIZER INC. | 3 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| UROGEN PHARMA, INC. | 1 | $31 |
| Olympus America Inc. | 1 | $25 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| IMMUNITYBIO, INC. | 1 | $20 |
| COLOPLAST CORP | 1 | $19 |
Products named: ERLEADA, PROVENGE, Xtandi, ORGOVYX, PLUVICTO, iTIND System, GEMTESA, JOURNAVX.
Industry payments across MS — which companies pay providers there.
